16 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
25677656	7	A novel molecule with notable activity against multi-drug resistant tuberculosis.	University of Georgia
21030469	31	Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors.	University of Minnesota
22822035	10	Mechanistic studies on the absorption and disposition of scutellarin in humans: selective OATP2B1-mediated hepatic uptake is a likely key determinant for its unique pharmacokinetic characteristics.	Chinese Academy of Sciences
21346002	5	Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms.	Toyama Chemical
21177485	7	Glucuronidation of the red clover isoflavone irilone by liver microsomes from different species and human UDP-glucuronosyltransferases.	Max Rubner-Institute
23132334	28	In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.	Glaxosmithkline
15781124	12	UDP-glucuronosyltransferases and clinical drug-drug interactions.	The University of British Columbia
32324396	17	p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators.	China Pharmaceutical University
30938524	21	Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir.	TBA
30623649	13	Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.	Gwangju Institute of Science and Technology
29548573	14	Identification of second-generation P2X3 antagonists for treatment of pain.	Merck